Clinical evaluation of the cardiac effects of new psychotropic drugs
暂无分享，去创建一个
[1] J. Ritchie,et al. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. , 1982, The New England journal of medicine.
[2] S. Montgomery,et al. A double blind comparison of zimelidine and amitriptyline in endogenous depression , 1981, Acta psychiatrica Scandinavica. Supplementum.
[3] Iain M McIntyre,et al. CARDIOVASCULAR EFFECTS OF NOMIFENSINE , 1978, The Lancet.
[4] G. Burrows,et al. CARDIOLOGICAL EFFECTS OF NOMIFENSINE, A NEW ANTIDEPRESSANT* , 1978, The Medical journal of Australia.
[5] G. Burrows,et al. Cardiac Effects of Different Tricyclic Antidepressant Drugs , 1976, British Journal of Psychiatry.
[6] G. Burrows,et al. Plasma concentration of nortriptyline and clinical response in depressive illness. , 1972, Lancet.
[7] E. S. Kristiansen. CARDIAC COMPLICATIONS DURING TREATMENT WITH IMIPRAMIN (TOFRANIL) , 1961, Acta psychiatrica Scandinavica.
[8] Trevor R. Norman,et al. Cardiovascular effects of antidepressants , 1981 .
[9] B. Walsh,et al. Cardiovascular effects of the tricyclic antidepressants: implications for new research , 1981 .
[10] Iain M McIntyre,et al. Plasma nomifensine concentration. Cardiological effects and clinical response. , 1980, International pharmacopsychiatry.
[11] S. E. Freeman,et al. Cardiological studies with nomifensine, a new antidepressant , 1979 .